Biography
Dr. Nechama Cohen, an observant Jewish mother diagnosed with Type I Diabetes, succeeded to find a way to control her condition and maintain a traditional Jewish lifestyle. In 1985 using her background in nutrition, social work, and nursing, she founded the Jewish Diabetes Association to help others - even those without health issues - but wanted to live a healthy lifestyle in order to prevent diabetes and health-related issues.
Research Interest
Dr. Nechama Cohen, an observant Jewish mother diagnosed with Type I Diabetes, succeeded to find a way to control her condition and maintain a traditional Jewish lifestyle. In 1985 using her background in nutrition, social work, and nursing, she founded the Jewish Diabetes Association to help others - even those without health issues - but wanted to live a healthy lifestyle in order to prevent diabetes and health-related issues.
Biography
Dr. Vladimir Tolstikov was awarded PhD degree at the age of 28 years from the Institute of Chemical Means for Plant Protection, Moscow, Russia. He is the director of Metabolomics at BERG LLC, USA. He has published more than 60 papers in reputed journals, 5 book chapters and has been serving as an editorial board member of MDPI Metabolites. During his career, he was working in leading research academic institutions and industry including Russian Academy of Medical Sciences, Max Plank Institute, UC Davis, Eli Lilly and Company and others. He is a pioneer in HILIC separations development applied to global Metabolomics. He has participated and contributed to an organization of various international meetings. His current research interests are in the field of AI-guided multi-omics input into the Precision Medicine development.
Research Interest
Dr. Vladimir Tolstikov was awarded PhD degree at the age of 28 years from the Institute of Chemical Means for Plant Protection, Moscow, Russia. He is the director of Metabolomics at BERG LLC, USA. He has published more than 60 papers in reputed journals, 5 book chapters and has been serving as an editorial board member of MDPI Metabolites. During his career, he was working in leading research academic institutions and industry including Russian Academy of Medical Sciences, Max Plank Institute, UC Davis, Eli Lilly and Company and others. He is a pioneer in HILIC separations development applied to global Metabolomics. He has participated and contributed to an organization of various international meetings. His current research interests are in the field of AI-guided multi-omics input into the Precision Medicine development.